Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma

European Journal of Surgical Oncology

Volumn 35, Issue 6, 2009, Pages 600-604

  Van den broeck, A ^a   Sergeant, G ^a   Ectors, N ^a   Van Steenbergen, W ^a   Aerts, R ^a   Topal, B ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cancer; Pancreas; Recurrence; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RECURRENT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 67349113897     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.12.006     Document Type: Article

References (23)

1. Exocrine pancreas. American Joint Committee on Cancer: AJCC Cancer Staging Manual (2002), Springer, New York pp. 157-64
2. Wagner M., Redaelli C., Lietz M., et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91 (2004) 586-594
3. Griffin J.F., Smalley S.R., Jewell W., et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66 (1990) 56-61
4. Howard T.J., Krug J.E., Yu J., et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10 (2006) 1338-1345 [discussion 1345-6]
5. Winter J.M., Cameron J.L., Campbell K.A., et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10 (2006) 1199-1210 [discussion 1210-1]
6. Ozaki H., Hiraoka T., Mizumoto R., et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 29 (1999) 16-22
7. Barugola G., Falconi M., Bettini R., et al. The determinant factors of recurrence following resection for ductal pancreatic cancer. JOP 8 (2007) 132-140
8. Westerdahl J., Andren-Sandberg A., and Ihse I. Recurrence of exocrine pancreatic cancer - local or hepatic?. Hepatogastroenterology 40 (1993) 384-387
9. Takahashi S., Ogata Y., Miyazaki H., et al. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J Surg 19 (1995) 653-659 [discussion 660]
10. Kayahara M., Nagakawa T., Ueno K., et al. An Evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72 (1993) 2118-2123
11. Fernandez-Cruz L., Johnson C., and Dervenis C. Locoregional dissemination and extended lymphadenectomy in pancreatic cancer. Dis Surg 16 (1999) 313-319
12. Esposito I., Kleeff J., Bergmann F., et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15 (2008) 1651-1660
13. Verbeke C.S. Resection margins and R1 rates in pancreatic cancer - are we there yet?. Histopathology 52 (2008) 787-796
14. Verbeke C.S., Leitch D., Menon K.V., et al. Redefining the R1 resection pancreatic cancer. Br J Surg 93 (2006) 1232-1237
15. Raut C.P., Tseng J.F., Sun C.C., et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246 (2007) 52-60
16. Vogel I., Kalthoff H., Henne-Bruns D., and Kremer B. Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma. Pancreatology 2 (2002) 79-88
17. Hirota M., Shimada S., Yamamoto K., et al. Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. JOP 6 (2005) 143-151
18. Oettle H., Post S., Neuhaus P., et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297 (2007) 267-277
19. Regine W.F., Winter K.A., Abrams R.A., et al. Luorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 299 (2008) 1019-1026
20. Yamamoto K., Shimada S., Hirota M., et al. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol 27 (2005) 1321-1328
21. Evans D.B., Termuhlen P.M., Byrd D.R., et al. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg 218 (1993) 54-60
22. Sindelar W.F., and Kinsella T.J. Studies of intraoperative radiation therapy in carcinoma of the pancreas. Ann Oncol 10 (1999) 226-230
23. Hayashibe A., Kameyama M., Shinbo M., and Makimoto S. Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer. Ann Surg Oncol 14 (2007) 190-194